Phospholamban antisense treatment attenuates hallmarks of disease in PLN R14del human iPSC derived cardiomyocytes

21 May 2023 (16:25 - 16:34)
Organised by: Logo
Congress Presentation Part of: From bedside to bench and back Cardiomyopathies HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by